Skip to content

Author

V. D. De Giusti

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Targeting the RH domain of GRK2: potential therapeutic implications in cardiovascular disease.

AIMS GRK2 is a key regulator of GPCR desensitization through its kinase and RGS homology (RH) domains. Because increased GRK2 activity contribute to cardiovascular diseases, including heart failure, cardiac hypertrophy and hypertension, GRK2 has emerged as an attractive therapeutic target. Most GRK2 inhibitors target i...

Emiliana B. Echeverría, V. Martínez, Sofía L. Acebedo et al. · 0 citations
Open access Sep 2026

Methyl-substituted 1,10-phenanthroline derivatives in copper(II) complexes enhance antitumor activity and inhibit NHE1 in MDA-MB-231 breast cancer cells

NHE1 is identified as a key molecular target underlying the enhanced antitumor activity of methylated phenanthroline copper(II) complexes, and ligand methylation enhances the antitumor activity of copper(II) complexes and shifts their mechanism of action from DNA damage-driven cytotoxicity toward ROS-mediated apoptosis...

K. S. Muñoz Garzón, V. D. De Giusti, C. Y. Fernández et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.